Results 131 to 140 of about 1,245,601 (334)
Failure of Splenectomy to Ameliorate Portal Hypertension in Myeloproliferative Disorders
The correct treatment of portal hypertension associated with myeloproliferative disorders remains uncertain. Splenectomy has been advocated by some to eliminate the forward flow component of the portal hypertension and thus reduce portal pressure.
Samuel S Lee+4 more
doaj +1 more source
Endoscopic ultrasonography - emerging applications in hepatology [PDF]
The inspection of the liver is a valuable part of the upper endoscopic ultrasonography (EUS) studies, regardless of the primary indication for the examination.
Castro, Francisca Dias de+5 more
core +1 more source
Portal hypertension in children [PDF]
Recommended approaches to the management of portal hypertension and esophageal varices in children continue to rely on expert opinion, low‐quality pediatric studies, and the extrapolation of the results of studies in adult populations. There is a pressing need for high‐quality pediatric studies, and expert panels recently have itemized the priorities ...
openaire +3 more sources
The role of the liver histological and necroinflammatory activity in the development of portal hypertension syndrome [PDF]
Background. Liver cirrhosis is the most often cause of the portal hypertension syndrome development, though structural and morphological liver remodeling usually begins on the stage of chronic hepatitis.
Dzyubanovsky I.Ya.+4 more
doaj
Balloon occlusion retrograde transvenous obliteration of gastric varices in two non-cirrhotic patients with portal vein thrombosis [PDF]
This report describes two non-cirrhotic patients with portal vein thrombosis who underwent successful balloon occlusion retrograde transvenous obliteration (BRTO) of gastric varices with a satisfactory response and no complications.
Borghei, Peyman+2 more
core +2 more sources
Primary liver cancer often occurs in patients with hepatitis and cirrhosis. Some patients have portal hypertension due to cirrhosis, and present with varying degrees of collateral circulation, splenomegaly and hypersplenism, ascites, and liver ...
Zhenkang Qiu, Gui Song Wang, Fei Gao
doaj
Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
Aim. This paper is aimed at reviewing existing literature that investigates the role of angiogenesis in portal hypertension pathogenesis in liver cirrhosis and the possibilities of its antiangiogenic therapy, along with the description of angiogenesis ...
D. V. Garbuzenko
doaj +1 more source
Advances and challenges in cirrhosis and portal hypertension
BackgroundLiver cirrhosis is the fourth cause of death in adults in Western countries, with complications of portal hypertension being responsible for most casualties.
A. Berzigotti
semanticscholar +1 more source